IBRX

Biotechnology BMYMP DGX DVA EHC ENSG FHLC FXH IBRX IHI IXJ IYH MCK MRK MRNA THC Uncategorized VHT XLV ZBH

Top 10 Healthcare Stocks of February

Mar 2, 2026

Biotechnology IBRX Uncategorized

ImmunityBio forms Irish unit, distribution deal to improve Anktiva access in Europe

Feb 19, 2026

Biotechnology IBRX Uncategorized

ImmunityBio rises after EU approval of bladder cancer therapy

Feb 18, 2026

Biotechnology IBRX Uncategorized

ImmunityBio rally causes $492M paper losses for short sellers

Jan 21, 2026

Biotechnology IBRX Uncategorized

ImmunityBio extends gains after FDA views on Anktiva label expansion

Jan 20, 2026

immunitybio-shares-climb-as-bladder-cancer-trial-nears-full-enrollment,-bla-submission-expected-by-year-end

Biotechnology IBRX Uncategorized

ImmunityBio shares climb as bladder cancer trial nears full enrollment, BLA submission expected by year-end

Jan 16, 2026

On the Move Comments (18) Chatchai Limjareon ImmunityBio (IBRX) on Friday said that enrollment in...

immunitybio-gains-as-anktiva-powers-over-400%-q4-sales-growth

Biotechnology IBRX Uncategorized

ImmunityBio gains as Anktiva powers over 400% Q4 sales growth

Jan 15, 2026

Comments (12) mohd izzuan ImmunityBio (IBRX) shares traded higher on Thursday after the company announced...

Biotechnology IBRX Uncategorized

ImmunityBio rises after Saudi approval of Anktiva for bladder cancer

Jan 14, 2026

immunitybio-releases-data-on-anktiva-for-non-small-cell-lung-cancer

Biotechnology IBRX Uncategorized

ImmunityBio releases data on Anktiva for non-small cell lung cancer

Jan 13, 2026

Comments (4) pada smith/iStock via Getty Images ImmunityBio (IBRX) has released positive data on its...

Biotechnology BMY CYTK GSK IBRX MRK MRNA NONOF NVO Uncategorized

ImmunityBio, Moderna among winners of EU drug recommendations this week

Dec 12, 2025